3.25.2 html 139 160 1 true 47 0 false 11 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.evaxion-biotech.com/20250630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Unaudited Condensed Consolidated Interim Statements of Comprehensive Loss Sheet http://www.evaxion-biotech.com/20250630/role/statement-unaudited-condensed-consolidated-interim-statements-of-comprehensive-loss Unaudited Condensed Consolidated Interim Statements of Comprehensive Loss Statements 2 false false R3.htm 002 - Statement - Unaudited Condensed Consolidated Interim Statements of Financial Position Sheet http://www.evaxion-biotech.com/20250630/role/statement-unaudited-condensed-consolidated-interim-statements-of-financial-position Unaudited Condensed Consolidated Interim Statements of Financial Position Statements 3 false false R4.htm 003 - Statement - Unaudited Condensed Consolidated Interim Statements of Changes in Equity (Deficit) Sheet http://www.evaxion-biotech.com/20250630/role/statement-unaudited-condensed-consolidated-interim-statements-of-changes-in-equity-deficit Unaudited Condensed Consolidated Interim Statements of Changes in Equity (Deficit) Statements 4 false false R5.htm 004 - Statement - Unaudited Condensed Consolidated Interim Statements of Cash Flows Sheet http://www.evaxion-biotech.com/20250630/role/statement-unaudited-condensed-consolidated-interim-statements-of-cash-flows Unaudited Condensed Consolidated Interim Statements of Cash Flows Statements 5 false false R6.htm 005 - Disclosure - Note 1 - General Company Information Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-1-general-company-information Note 1 - General Company Information Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Liquidity and Going Concern Assessment Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-2-liquidity-and-going-concern-assessment Note 2 - Liquidity and Going Concern Assessment Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-3-summary-of-significant-accounting-policies Note 3 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Significant Accounting Judgements, Estimates, and Assumptions Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-4-significant-accounting-judgements-estimates-and-assumptions Note 4 - Significant Accounting Judgements, Estimates, and Assumptions Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Revenue Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-5-revenue Note 5 - Revenue Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Financial Instruments and Risk Management Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management Note 6 - Financial Instruments and Risk Management Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Borrowings Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings Note 7 - Borrowings Notes 12 false false R13.htm 012 - Disclosure - Note 8 - Share-based Payments Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments Note 8 - Share-based Payments Notes 13 false false R14.htm 013 - Disclosure - Note 9 - Financial Income and Expenses Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-9-financial-income-and-expenses Note 9 - Financial Income and Expenses Notes 14 false false R15.htm 014 - Disclosure - Note 10 - Capital Structure and Financial Matters Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters Note 10 - Capital Structure and Financial Matters Notes 15 false false R16.htm 015 - Disclosure - Note 11 - Commitments and Contingencies Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-11-commitments-and-contingencies Note 11 - Commitments and Contingencies Notes 16 false false R17.htm 016 - Disclosure - Note 12 - Events After the Reporting Period Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-12-events-after-the-reporting-period Note 12 - Events After the Reporting Period Notes 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.evaxion-biotech.com/20250630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.evaxion-biotech.com/20250630/role/statement-note-3-summary-of-significant-accounting-policies 18 false false R19.htm 018 - Disclosure - Note 6 - Financial Instruments and Risk Management (Tables) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management-tables Note 6 - Financial Instruments and Risk Management (Tables) Tables http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management 19 false false R20.htm 019 - Disclosure - Note 7 - Borrowings (Tables) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings-tables Note 7 - Borrowings (Tables) Tables http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings 20 false false R21.htm 020 - Disclosure - Note 8 - Share-based Payments (Tables) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments-tables Note 8 - Share-based Payments (Tables) Tables http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments 21 false false R22.htm 021 - Disclosure - Note 9 - Financial Income and Expenses (Tables) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-9-financial-income-and-expenses-tables Note 9 - Financial Income and Expenses (Tables) Tables http://www.evaxion-biotech.com/20250630/role/statement-note-9-financial-income-and-expenses 22 false false R23.htm 022 - Disclosure - Note 10 - Capital Structure and Financial Matters (Tables) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters-tables Note 10 - Capital Structure and Financial Matters (Tables) Tables http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters 23 false false R24.htm 023 - Disclosure - Note 2 - Liquidity and Going Concern Assessment (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-2-liquidity-and-going-concern-assessment-details-textual Note 2 - Liquidity and Going Concern Assessment (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-2-liquidity-and-going-concern-assessment 24 false false R25.htm 024 - Disclosure - Note 5 - Revenue (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-5-revenue-details-textual Note 5 - Revenue (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-5-revenue 25 false false R26.htm 025 - Disclosure - Note 6 - Financial Instruments and Risk Management (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management-details-textual Note 6 - Financial Instruments and Risk Management (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management-tables 26 false false R27.htm 026 - Disclosure - Note 6 - Financial Instruments and Risk Management - Disclosure of Fair Value Measurements of Liabilities (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management-disclosure-of-fair-value-measurements-of-liabilities-details Note 6 - Financial Instruments and Risk Management - Disclosure of Fair Value Measurements of Liabilities (Details) Details 27 false false R28.htm 027 - Disclosure - Note 6 - Financial Instruments and Risk Management - Schedule of Warrant Liabilities (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-6-financial-instruments-and-risk-management-schedule-of-warrant-liabilities-details Note 6 - Financial Instruments and Risk Management - Schedule of Warrant Liabilities (Details) Details 28 false false R29.htm 028 - Disclosure - Note 7 - Borrowings (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings-details-textual Note 7 - Borrowings (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings-tables 29 false false R30.htm 029 - Disclosure - Note 7 - Borrowings - Schedule of Borrowings (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-7-borrowings-schedule-of-borrowings-details Note 7 - Borrowings - Schedule of Borrowings (Details) Details 30 false false R31.htm 030 - Disclosure - Note 8 - Share-based Payments (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments-details-textual Note 8 - Share-based Payments (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments-tables 31 false false R32.htm 031 - Disclosure - Note 8 - Share-based Payments - Warrant Activity (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-payments-warrant-activity-details Note 8 - Share-based Payments - Warrant Activity (Details) Details 32 false false R33.htm 032 - Disclosure - Note 8 - Share-based Compensation - Warrant Assumptions (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-8-sharebased-compensation-warrant-assumptions-details Note 8 - Share-based Compensation - Warrant Assumptions (Details) Details 33 false false R34.htm 033 - Disclosure - Note 9 - Financial Income and Expenses - Components of Financial Income and Expenses (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-9-financial-income-and-expenses-components-of-financial-income-and-expenses-details Note 9 - Financial Income and Expenses - Components of Financial Income and Expenses (Details) Details 34 false false R35.htm 034 - Disclosure - Note 10 - Capital Structure and Financial Matters (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters-details-textual Note 10 - Capital Structure and Financial Matters (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters-tables 35 false false R36.htm 035 - Disclosure - Note 10 - Capital Structure and Financial Matters - Schedule of Share Capital (Details) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-10-capital-structure-and-financial-matters-schedule-of-share-capital-details Note 10 - Capital Structure and Financial Matters - Schedule of Share Capital (Details) Details 36 false false R37.htm 036 - Disclosure - Note 12 - Events After the Reporting Period (Details Textual) Sheet http://www.evaxion-biotech.com/20250630/role/statement-note-12-events-after-the-reporting-period-details-textual Note 12 - Events After the Reporting Period (Details Textual) Details http://www.evaxion-biotech.com/20250630/role/statement-note-12-events-after-the-reporting-period 37 false false All Reports Book All Reports evax-20250630.xsd evax-20250630_cal.xml evax-20250630_def.xml evax-20250630_lab.xml evax-20250630_pre.xml evax20250806_6k.htm ex_848977.htm http://xbrl.sec.gov/dei/2024 https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full true true